NZ540518A - Novel x-conotoxin peptides (-I) - Google Patents

Novel x-conotoxin peptides (-I)

Info

Publication number
NZ540518A
NZ540518A NZ540518A NZ54051803A NZ540518A NZ 540518 A NZ540518 A NZ 540518A NZ 540518 A NZ540518 A NZ 540518A NZ 54051803 A NZ54051803 A NZ 54051803A NZ 540518 A NZ540518 A NZ 540518A
Authority
NZ
New Zealand
Prior art keywords
cys
xaal
seq
peptide
lys leu
Prior art date
Application number
NZ540518A
Other languages
English (en)
Inventor
Richard James Lewis
Paul Francis Alewood
Dianne Alewood
Elka Palant
Original Assignee
Xenome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenome Ltd filed Critical Xenome Ltd
Publication of NZ540518A publication Critical patent/NZ540518A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ540518A 2002-12-02 2003-12-02 Novel x-conotoxin peptides (-I) NZ540518A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43030602P 2002-12-02 2002-12-02
PCT/AU2003/001605 WO2004050690A1 (en) 2002-12-02 2003-12-02 NOVEL χ-CONOTOXIN PEPTIDES (-I)

Publications (1)

Publication Number Publication Date
NZ540518A true NZ540518A (en) 2006-12-22

Family

ID=32469446

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ540518A NZ540518A (en) 2002-12-02 2003-12-02 Novel x-conotoxin peptides (-I)

Country Status (14)

Country Link
US (1) US7851444B2 (es)
EP (1) EP1572725B1 (es)
JP (1) JP4565087B2 (es)
AT (1) ATE547424T1 (es)
AU (1) AU2003302609B9 (es)
CA (1) CA2508129C (es)
CY (1) CY1112839T1 (es)
DK (1) DK1572725T3 (es)
ES (1) ES2383358T3 (es)
HK (1) HK1080870A1 (es)
NZ (1) NZ540518A (es)
PT (1) PT1572725E (es)
SI (1) SI1572725T1 (es)
WO (1) WO2004050690A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP1578787B1 (en) * 2002-12-02 2012-11-14 Xenome Ltd Novel chi-conotoxin peptides (-ii)
US8062623B2 (en) * 2004-10-15 2011-11-22 Velocys Stable, catalyzed, high temperature combustion in microchannel, integrated combustion reactors
WO2007047373A1 (en) * 2005-10-13 2007-04-26 Velocys, Inc. Microchannel apparatus comprising a platinum aluminide layer and chemical processes using the apparatus
CN102752032B (zh) * 2011-04-22 2015-04-22 艾利森电话股份有限公司 同频负载均衡方法及其设备
JP6731044B2 (ja) 2015-05-22 2020-07-29 クレムソン・ユニバーシティ・リサーチ・ファウンデーション 生物付着の抑止において用いるためのコノトキシンペプチド

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051403A (en) 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
AU642582B2 (en) 1991-02-25 1993-10-21 Eli Lilly And Company Treatment of lower urinary tract disorders
SG50624A1 (en) 1991-12-30 1998-07-20 Neurex Corp Methods of producing analgesia and enhancing opiate analgesia
WO1996014079A1 (de) 1994-11-03 1996-05-17 Arzneimittelwerk Dresden Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
WO1996040064A1 (en) 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
DE69627153T2 (de) 1995-06-27 2003-12-04 Elan Pharmaceuticals Inc N D G Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
HU228356B1 (en) 1996-02-22 2013-03-28 Neurosearch As Tropane-derivatives, inhibiting neurotransmitter re-uptake, their preparation, pharmaceutical compositions containing them and use of the compounds
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
CZ288739B6 (cs) 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
AU735724B2 (en) 1996-11-18 2001-07-12 University Of Utah Research Foundation Use of conotoxin peptides ImI and MII as cardiovascular agents
DE69817557T2 (de) 1997-05-14 2004-06-17 Neurosearch A/S Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
WO2000044769A1 (en) 1999-01-29 2000-08-03 University Of Utah Research Foundation Conotoxin peptides
US6767896B1 (en) * 1999-01-29 2004-07-27 Cognetix, Inc. Conotoxin peptides
US20010036943A1 (en) 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
AU2002245340A1 (en) 2001-01-29 2002-08-12 Cognetix, Inc. B-superfamily conotoxins
WO2002064740A2 (en) * 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
EP1578787B1 (en) 2002-12-02 2012-11-14 Xenome Ltd Novel chi-conotoxin peptides (-ii)

Also Published As

Publication number Publication date
SI1572725T1 (sl) 2012-08-31
EP1572725A1 (en) 2005-09-14
PT1572725E (pt) 2012-05-28
DK1572725T3 (da) 2012-06-18
ES2383358T3 (es) 2012-06-20
JP2006523181A (ja) 2006-10-12
EP1572725B1 (en) 2012-02-29
AU2003302609B9 (en) 2008-05-15
AU2003302609A1 (en) 2004-06-23
EP1572725A4 (en) 2008-09-24
ATE547424T1 (de) 2012-03-15
CA2508129A1 (en) 2004-06-17
US20060142201A1 (en) 2006-06-29
WO2004050690A1 (en) 2004-06-17
CY1112839T1 (el) 2016-02-10
JP4565087B2 (ja) 2010-10-20
AU2003302609B2 (en) 2008-03-20
US7851444B2 (en) 2010-12-14
CA2508129C (en) 2012-06-26
HK1080870A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
US20090088389A1 (en) Novel x-conotoxin peptides (-ii)
EP1948685B1 (en) Mu-conotoxin peptides and use thereof as a local anesthetic
TW200902068A (en) GLP-1 peptide having sugar chain attached thereto
US20090197810A1 (en) Alpha conotoxin peptides with analgesic properties
CA2566832A1 (en) Cyclised alpha-conotoxin peptides
EP2015766B1 (en) Cyclised alpha-conotoxin vc1.1 for use in the oral treatment of pain
WO2008077194A1 (en) Receptor agonists
CA2508129C (en) Novel x-conotoxin peptides (-i)
NZ510813A (en) Synthetic X-conotoxin peptides as neuronal amide transporters
NZ540582A (en) Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis B core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
US8188048B2 (en) Combination therapy
WO2009021289A1 (en) Potassium channel inhibitors
AU757011B2 (en) Novel peptides
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
CN1854151B (zh) 多巴胺转运蛋白拟肽抑制剂及其应用
AU767850B2 (en) Novel peptides
WO2004099238A1 (en) NOVEL mu-CONOTOXIN PEPTIDES

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed